Loading...

Leonardo C Clavijo, MD, PhD

Title(s)Associate Professor of Clinical Medicine
AddressHCC 300N
Health Sciences Campus
Los Angeles CA 90089-9198
Phone+1 323 442 6130
vCardDownload vCard
    Other Positions
    Title(s)Director, Interventional Cardiology Fellowship Program


    Collapse Overview 
    Collapse Overview
    Dr. Clavijo's clinical interests include non-surgical treatment of complex vascular disease, peripheral arterial disease, peripheral vascular disease, carotid disease and interventional cardiology. His research interests include percutaneous coronary interventions, critical limb ischemia, endovascular treatment of peripheral arterial and venous vascular disease and vascular biology.

    Dr. Clavijo earned his medical degree from Universidad Nacional de Colombia. He then went on to complete his Masters of Science in Physiology & Biophysics and Doctor of Philosophy in Physiology & Biophysics from the University of Louisville School of Medicine.

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Factors associated with the use of bare metal stents in patients with ST elevation myocardial infarction. Cardiovasc Revasc Med. 2020 May 15. Raj L, Upadyhay R, Clavijo LC, Tun H, Mehra A, Hindoyan A, Matthews RV, Shavelle DM. PMID: 32448777.
      View in: PubMed   Mentions:    Fields:    
    2. Predictors of Major Adverse Limb Events after Open Forefoot Amputation in Patients with Chronic Limb-Threatening Ischemia. Ann Vasc Surg. 2020 Jul; 66:614-620. Zhang LL, Saldana-Ruiz N, Elsayed RS, Armstrong DG, Shin L, Magee GA, Woods AC, Clavijo LC, Rowe VL. PMID: 32027986.
      View in: PubMed   Mentions:    Fields:    
    3. Therapeutic Window of Clopidogrel and Ticagrelor in Patients With Critical Limb-Threatening Ischemia. J Cardiovasc Pharmacol Ther. 2020 03; 25(2):158-163. Dhillon AS, Caro J, Tun H, Armstrong DG, Rowe V, Shavelle DM, Clavijo LC. PMID: 31550912.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. "The Renal Foot" - Angiographic Pattern of Patients with Chronic Limb Threatening Ischemia and End-Stage Renal Disease. Cardiovasc Revasc Med. 2020 01; 21(1):118-121. Baghdasaryan PA, Bae JH, Yu W, Rowe V, Armstrong DG, Shavelle DM, Clavijo LC. PMID: 31575468.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    5. Anticoagulation Patterns in Patients with Atrial Fibrillation Following Percutaneous Coronary Intervention in an Academic Center. J Innov Card Rhythm Manag. 2019 Aug; 10(8):3785-3789. Rusia A, Kita KY, Shah SD, Roy D, Zhang Y, Nattiv J, Doshi N, Tun H, Clavijo LC, Doshi RN. PMID: 32477745.
      View in: PubMed   Mentions:
    6. How to Create a Hot Foot Line to Prevent Diabetes-Related Amputations: Instant Triage for Emergency Department and Inpatient Consultations. J Am Podiatr Med Assoc. 2019 Mar; 109(2):174-179. Miller JD, Lew EJ, Giovinco NA, Ochoa C, Rowe VL, Clavijo LC, Weaver F, Armstrong DG. PMID: 31135194.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. In-Hospital Outcomes of Rotational Atherectomy in High-Risk Patients With Severely Calcified Left Main Coronary Artery Disease: A Single-Center Experience. J Invasive Cardiol. 2019 04; 31(4):101-106. Dhillon AS, Narayanan MR, Tun H, Hindoyan A, Matthews R, Mehra A, Shavelle DM, Clavijo LC. PMID: 30643039.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Successful Implementation of Extracorporeal Membrane Oxygenation Support as a Bridge to Heart-Lung Transplantation in an Eisenmenger's Syndrome Patient With Paradoxical Coronary Embolism. J Investig Med High Impact Case Rep. 2019 Jan-Dec; 7:2324709619846575. Zhang J, Patel S, Clavijo L, Laughrun D. PMID: 31053036.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Use of the STEMI Team for Treatment of Patients With Pulmonary Embolism: A Pilot Study. J Invasive Cardiol. 2018 10; 30(10):367-371. Kendall MR, Swadron S, Clavijo LC, Mehra AK, Hindoyan A, Matthews RV, Shavelle DM. PMID: 30279292.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Long-term outcomes of drug-eluting stents versus bare metal stents in saphenous vein graft interventions. Evidence from a meta-analysis of randomized controlled trials. Cardiovasc Revasc Med. 2018 12; 19(8):951-955. Nairooz R, Saad M, Dhillon AS, Yousaf H, Awar L, Mehra A, Matthews RV, Shavelle D, Clavijo L. PMID: 30078629.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Incidence and treatment of severe primary mitral regurgitation in contemporary clinical practice. Cardiovasc Revasc Med. 2018 12; 19(8):960-963. Wu S, Chai A, Arimie S, Mehra A, Clavijo L, Matthews RV, Shavelle DM. PMID: 30060923.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Comparison of devices used in carotid artery stenting: A vascular quality initiative analysis of commonly used carotid stents and embolic protection devices. Catheter Cardiovasc Interv. 2018 10 01; 92(4):743-749. Dhillon AS, Li S, Lewinger JP, Shavelle DM, Matthews RV, Clavijo LC, Weaver FA, Garg P. PMID: 30019819.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Prevalence of high on-treatment (aspirin and clopidogrel) platelet reactivity in patients with critical limb ischemia. Cardiovasc Revasc Med. 2018 07; 19(5 Pt A):516-520. Clavijo LC, Al-Asady N, Dhillon A, Matthews RV, Caro J, Tun H, Rowe V, Shavelle DM. PMID: 29221961.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    14. Switch to Ticagrelor in critical limb ischemia antiplatelet study (STT-CLIPS). Cardiovasc Revasc Med. 2018 Apr - May; 19(3 Pt B):319-323. Clavijo LC, Dhillon A, Al-Asady N, Matthews RV, Caro J, Tun H, Rowe V, Shavelle DM. PMID: 29329963.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    15. Computerized tomography angiography by direct intra-aortic low volume contrast injection in patients being evaluated for EVAR. Vascular. 2017 Oct; 25(5):451-458. Teixeira PG, Clavijo LC, Wilcox AG, Weaver FA. PMID: 28118783.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Increased risk of mortality after lower extremity bypass in individuals with acute kidney injury in the Vascular Quality Initiative. J Vasc Surg. 2017 Apr; 65(4):1055-1061. Flores E, Lewinger JP, Rowe VL, Woo K, Weaver FA, Shavelle D, Clavijo L, Garg PK. PMID: 27865637.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    17. Outcomes of Critical Limb Ischemia in an Urban, Safety Net Hospital Population with High WIfI Amputation Scores. Ann Vasc Surg. 2017 Jan; 38:84-89. Ward R, Dunn J, Clavijo L, Shavelle D, Rowe V, Woo K. PMID: 27546850.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    18. Association of elevated triglycerides and acute myocardial infarction in young Hispanics. Cardiovasc Revasc Med. 2016 Dec; 17(8):510-514. Essilfie G, Shavelle DM, Tun H, Platt K, Kobayashi R, Mehra A, Matthews RV, Clavijo L, Gaglia MA. PMID: 27432210.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    19. Same-day discharge after coronary stenting and femoral artery device closure: A randomized study in stable and low-risk acute coronary syndrome patients. Cardiovasc Revasc Med. 2016 Apr-May; 17(3):155-61. Clavijo LC, Cortes GA, Jolly A, Tun H, Mehra A, Gaglia MA, Shavelle D, Matthews RV. PMID: 27157292.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    20. Platelet inhibition with ticagrelor versus clopidogrel in Hispanic patients with stable coronary artery disease with or without diabetes mellitus. Cardiovasc Revasc Med. 2015 Dec; 16(8):450-4. Clavijo LC, Maya J, Carlson G, Angiolillo DJ, Teng R, Caplan R, Price MJ. PMID: 26440227.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    21. Critical limb ischemia. Cardiol Clin. 2015 Feb; 33(1):37-47. Elsayed S, Clavijo LC. PMID: 25439329.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    22. Vascular disease. Preface. Cardiol Clin. 2015 Feb; 33(1):ix. Clavijo LC. PMID: 25439338.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    23. A randomised trial of the pharmacodynamic and pharmacokinetic effects of ticagrelor compared with clopidogrel in Hispanic patients with stable coronary artery disease. J Thromb Thrombolysis. 2015 Jan; 39(1):8-14. Price MJ, Clavijo L, Angiolillo DJ, Carlson G, Caplan R, Teng R, Maya J. PMID: 25305090.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    24. Antiplatelet therapy for peripheral arterial disease and critical limb ischemia: guidelines abound, but where are the data? J Cardiovasc Pharmacol Ther. 2015 Mar; 20(2):144-56. Azarbal A, Clavijo L, Gaglia MA. PMID: 25079473.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    25. African-American patients are less likely to receive drug-eluting stents during percutaneous coronary intervention. Cardiovasc Revasc Med. 2014 Jun; 15(4):214-8. Gaglia MA, Shavelle DM, Tun H, Bhatt J, Mehra A, Matthews RV, Clavijo L. PMID: 24814420.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    26. Cardiovascular pharmacology core reviews: aspirin. J Cardiovasc Pharmacol Ther. 2013 Nov; 18(6):505-13. Gaglia MA, Clavijo L. PMID: 24057863.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    27. Use of regadenoson for measurement of fractional flow reserve. Catheter Cardiovasc Interv. 2014 Feb 15; 83(3):369-74. Prasad A, Zareh M, Doherty R, Gopal A, Vora H, Somma K, Mehra A, Clavijo LC, Matthews RV, Shavelle DM. PMID: 23765847.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    28. Recalcitrant peroneal artery pseudoaneurysm in a patient with Hemophilia B. Cardiovasc Revasc Med. 2013 Nov-Dec; 14(6):359-62. Gopal A, Aranson N, Woo K, Clavijo L, Shavelle DM. PMID: 23773548.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    29. Devices to treat peripheral chronic total occlusions. J Interv Cardiol. 2012 Aug; 25(4):395-403. Al-Ameri H, Clavijo L, Matthews RV, Kloner RA, Shavelle DM. PMID: 22564193.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    30. Percutaneous left ventricular support for high-risk PCI and cardiogenic shock: who gets what? Cardiovasc Revasc Med. 2012 Mar-Apr; 13(2):101-5. Shah R, Thomson A, Atianzar K, Somma K, Mehra A, Clavijo L, Matthews RV, Shavelle DM. PMID: 22406055.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    31. Percutaneous devices to support the left ventricle. Expert Rev Med Devices. 2011 Nov; 8(6):681-94. Shavelle DM, Clavijo L, Matthews RV. PMID: 22029466.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    32. Acute ST segment elevation during exercise stress echocardiography due to severe pulmonary hypertension. Cardiovasc Ultrasound. 2011 Jun 06; 9:18. Nguyen TH, Clavijo LC, Naqvi TZ. PMID: 21645399.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    33. Cerebral vasospasm and concurrent left ventricular outflow tract obstruction: requirement for modification of hyperdynamic therapy regimen. Neurocrit Care. 2010 Apr; 12(2):265-8. Zada G, Terterov S, Russin J, Clavijo L, Giannotta S. PMID: 19816811.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    34. Use of drug-eluting versus bare-metal stents in ST-segment elevation myocardial infarction. J Invasive Cardiol. 2009 Nov; 21(11):E206-12. Chen SF, El-Bialy A, Matthews R, Clavijo L. PMID: 19901420.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    35. Revascularization of carotid stenosis before cardiac surgery. Expert Rev Cardiovasc Ther. 2008 Nov; 6(10):1393-6. Das P, Clavijo LC, Nanjundappa A, Dieter RS. PMID: 19018692.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    36. Interanimal variability in preexisting collaterals is a major factor determining outcome in experimental angiogenesis trials. Am J Physiol Heart Circ Physiol. 2007 Apr; 292(4):H1891-7. Zbinden S, Clavijo LC, Kantor B, Morsli H, Cortes GA, Andrews JA, Jang GJ, Burnett MS, Epstein SE. PMID: 17189353.
      View in: PubMed   Mentions: 16     Fields:    Translation:Animals
    37. Sirolimus-eluting stents and calcified coronary lesions: clinical outcomes of patients treated with and without rotational atherectomy. Catheter Cardiovasc Interv. 2006 Dec; 68(6):873-8. Clavijo LC, Steinberg DH, Torguson R, Kuchulakanti PK, Chu WW, Fournadjiev J, Satler LF, Kent KM, Suddath WO, Waksman R, Pichard AD. PMID: 17086529.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    38. Comparison of clinical outcomes of overlapping sirolimus- versus paclitaxel-eluting stents in patients undergoing percutaneous coronary intervention. Am J Cardiol. 2006 Dec 15; 98(12):1563-6. Chu WW, Kuchulakanti PK, Torguson R, Wang B, Clavijo LC, Suddath WO, Pichard AD, Satler LF, Kent KM, Waksman R. PMID: 17145210.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    39. Comparison of paclitaxel-eluting stent and sirolimus-eluting stent expansion at incremental delivery pressures. Cardiovasc Revasc Med. 2006 Oct-Dec; 7(4):208-11. Javaid A, Chu WW, Cheneau E, Clavijo LC, Satler LF, Kent KM, Weissman NJ, Pichard AD, Waksman R. PMID: 17174865.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    40. Impact of three or more sirolimus-eluting stents versus paclitaxel-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv. 2006 Jul; 68(1):62-6. Chu WW, Kuchulakanti PK, Torguson R, Wang B, Clavijo LC, Suddath WO, Pichard AD, Satler LF, Kent KM, Waksman R. PMID: 16755592.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    41. Bivalirudin versus unfractionated heparin in patients undergoing percutaneous coronary intervention after acute myocardial infarction. Cardiovasc Revasc Med. 2006 Jul-Sep; 7(3):132-5. Chu WW, Kuchulakanti PK, Wang B, Torguson R, Clavijo LC, Pichard AD, Suddath WO, Satler LF, Kent KM, Waksman R. PMID: 16945819.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    42. Sirolimus-eluting stents versus Paclitaxel-eluting stents in the treatment of coronary artery disease in patients with diabetes mellitus. Am J Cardiol. 2006 Jul 15; 98(2):187-92. Kuchulakanti PK, Chu WW, Torguson R, Clavijo L, Wolfram R, Mishra S, Xue Z, Gevorkian N, Suddath WO, Satler LF, Kent KM, Pichard AD, Waksman R. PMID: 16828590.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    43. Impact of overlapping drug-eluting stents in patients undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv. 2006 Apr; 67(4):595-9. Chu WW, Kuchulakanti PK, Torguson R, Wang B, Clavijo LC, Suddath WO, Pichard AD, Satler LF, Kent KM, Waksman R. PMID: 16532495.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    44. Efficacy of sirolimus-eluting stents as compared to paclitaxel-eluting stents for saphenous vein graft intervention. J Interv Cardiol. 2006 Apr; 19(2):121-5. Chu WW, Kuchulakanti PK, Wang B, Clavijo LC, Suddath WO, Pichard AD, Satler LF, Kent KM, Waksman R. PMID: 16650239.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    45. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation. 2006 Feb 28; 113(8):1108-13. Kuchulakanti PK, Chu WW, Torguson R, Ohlmann P, Rha SW, Clavijo LC, Kim SW, Bui A, Gevorkian N, Xue Z, Smith K, Fournadjieva J, Suddath WO, Satler LF, Pichard AD, Kent KM, Waksman R. PMID: 16490815.
      View in: PubMed   Mentions: 81     Fields:    Translation:Humans
    46. Effect of a rapid intra-arterial infusion of dextrose 5% prior to coronary angiography on frequency of contrast-induced nephropathy in high-risk patients. Am J Cardiol. 2006 Apr 01; 97(7):981-3. Clavijo LC, Pinto TL, Kuchulakanti PK, Torguson R, Chu WW, Satler LF, Kent KM, Suddath WO, Waksman R, Pichard AD. PMID: 16563900.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    47. Impact of chronic renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary intervention with sirolimus-eluting stents versus bare metal stents. Am J Cardiol. 2006 Mar 15; 97(6):792-7. Kuchulakanti PK, Torguson R, Chu WW, Canos DA, Rha SW, Clavijo L, Deible R, Gevorkian N, Suddath WO, Satler LF, Kent KM, Pichard AD, Waksman R. PMID: 16516578.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    48. Impact of three or more versus a single sirolimus-eluting stent on outcomes in patients who undergo percutaneous coronary intervention. Am J Cardiol. 2006 Mar 01; 97(5):606-10. Chu WW, Kuchulakanti PK, Rha SW, GebreEyesus A, Aggrey G, Torguson R, Wang B, Xue Z, Clavijo LC, Suddath WO, Pichard AD, Satler LF, Kent KM, Waksman R. PMID: 16490422.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    49. Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications. Cardiovasc Revasc Med. 2006 Jan-Mar; 7(1):7-11. Clavijo LC, Pinto TL, Kuchulakanti PK, Torguson R, Chu WW, Satler LF, Kent KM, Suddath WO, Pichard AD, Waksman R. PMID: 16513517.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    50. Bivalirudin compared with IIb/IIIa inhibitors in patients with in-stent restenosis undergoing intracoronary brachytherapy. Cardiovasc Revasc Med. 2005 Oct-Dec; 6(4):154-9. Kuchulakanti P, Wolfram R, Torguson R, Rha SW, Cheneau E, Clavijo L, Chu WW, Pinnow EE, Canos D, Satler LF, Suddath WO, Pichard AD, Kent KM, Waksman R. PMID: 16326376.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    51. Rapamycin attenuates atherosclerotic plaque progression in apolipoprotein E knockout mice: inhibitory effect on monocyte chemotaxis. J Cardiovasc Pharmacol. 2005 Oct; 46(4):481-6. Pakala R, Stabile E, Jang GJ, Clavijo L, Waksman R. PMID: 16160601.
      View in: PubMed   Mentions: 31     Fields:    Translation:AnimalsCells
    52. The potential role of resistin in atherogenesis. Atherosclerosis. 2005 Oct; 182(2):241-8. Burnett MS, Lee CW, Kinnaird TD, Stabile E, Durrani S, Dullum MK, Devaney JM, Fishman C, Stamou S, Canos D, Zbinden S, Clavijo LC, Jang GJ, Andrews JA, Zhu J, Epstein SE. PMID: 16159596.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansAnimalsCells
    53. Impact of treatment of coronary artery disease with sirolimus-eluting stents on outcomes of diabetic and nondiabetic patients. Am J Cardiol. 2005 Oct 15; 96(8):1100-6. Kuchulakanti PK, Torguson R, Canos D, Rha SW, Chu WW, Clavijo L, Deible R, Gevorkian N, Suddath WO, Satler LF, Kent KM, Pichard AD, Waksman R. PMID: 16214445.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    54. Sudden cardiac death in athlete with anomalous single coronary artery. Cardiovasc Revasc Med. 2005 Apr-Jun; 6(2):89-90. Mofrad PS, Weigold G, Clavijo LC. PMID: 16459367.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    55. MRI evaluation of a coronary artery perforation. Cardiovasc Revasc Med. 2005 Jan-Mar; 6(1):44-5. Clavijo LC, Yar O, Kuchulakanti P, Chu WW, Suddath WO, Satler LF, Kent KM, Waksman R, Pichard AD. PMID: 16263356.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    56. "Hybrid" approach for the treatment of a giant left main coronary artery aneurysm. Cardiovasc Radiat Med. 2004 Jul-Sep; 5(3):153-4. Clavijo LC, Kuchulakanti P, Chu WW, Weigold G, Pichard AD, Waksman R, Boyce SW, Satler LF, Kent KM. PMID: 15721852.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    57. Janus phenomenon: the interrelated tradeoffs inherent in therapies designed to enhance collateral formation and those designed to inhibit atherogenesis. Circulation. 2004 Jun 15; 109(23):2826-31. Epstein SE, Stabile E, Kinnaird T, Lee CW, Clavijo L, Burnett MS. PMID: 15197154.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimalsCells
    Leonardo's Networks
    Concepts (323)
    Derived automatically from this person's publications.
    _
    Co-Authors (19)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _